However, a majority of the IRF clones in both patients were detected in clusters 2 and 4 (NHL-6: 85.6%, NHL-7: 84.6%), which expressed high levels of genes associated with cytotoxicity and proliferation, respectively (Fig. 7c), despite the finding that these clusters only comprised 42.7% and 27.1% of cells in the IP in NHL-6 and NHL-7 (Fig. 6b), respectively. The gene discussed is TRIM63; the disease is non-Hodgkin lymphoma.